{"product_id":"hexarelin-5mg","title":"Hexarelin 5mg","description":"\u003cp\u003e\u003cimg src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/1007\/3581\/1927\/files\/HEXARELIN_5MG_GLOSS.png?v=1779039263\" alt=\"\"\u003e\u003c\/p\u003e\n\u003cp\u003eHexarelin is a synthetic hexapeptide research compound studied for its potential to stimulate growth hormone secretion. Designed for laboratory and research applications, this 5mg formulation offers precise dosing for controlled experimental protocols. Each vial contains pharmaceutical-grade material suitable for in vitro and animal model studies. Hexarelin has been the subject of scientific investigation into growth hormone dynamics and metabolic pathways. Ideal for researchers and institutions requiring high-purity peptide compounds for advanced studies.\u003c\/p\u003e\n\u003cp\u003ePeptide Sequence: His-D-2-methyl-Trp-Ala-Trp-D-Phe-Lys-NH2 Molecular Weight: 886.04 g\/mol Purity: ≥98% (HPLC) Physical Form: Lyophilized powder Vial Size: 5mg per vial Storage: Keep refrigerated at 2–8°C. Protect from light and moisture. Reconstitution: Dissolve in sterile water or bacteriostatic saline for injection. Research Applications: Growth hormone secretion studies, metabolic research, neuroendocrine investigations. Quality Assurance: Manufactured to pharmaceutical standards with certificate of analysis provided.\u003c\/p\u003e\n\u003cp\u003eMolecular Formula: C49H66N12O9 CAS Number: 140703-51-1 Empirical Composition: Carbon, hydrogen, nitrogen, and oxygen in hexapeptide structure with D-amino acid modifications. Structural Classification: Synthetic growth hormone-releasing peptide (GHRP) analogue.\u003c\/p\u003e\n\u003cp\u003eBefore Reconstitution (Lyophilized Powder): Store at 2–8°C in original sealed vial. Keep in a cool, dark place away from direct sunlight and moisture. Unopened vials remain stable for 24 months when stored properly. Avoid repeated temperature fluctuations. After Reconstitution (Solution): Once dissolved in sterile water or bacteriostatic saline, use immediately for optimal stability. If storage is necessary, keep reconstituted solution at 2–8°C for up to 7 days. For extended storage beyond one week, freeze at −20°C or below. Thaw at room temperature before use. Avoid multiple freeze-thaw cycles. Do not store at room temperature for extended periods.\u003c\/p\u003e\n\u003ch2\u003eResearch References\u003c\/h2\u003e\n\u003cp\u003eThe following peer-reviewed studies and publications are provided for informational and scientific reference purposes only. They do not constitute medical claims or endorsements of this product for any therapeutic use.\u003c\/p\u003e\n\u003col\u003e\n\u003cli\u003e\n\u003cstrong\u003eHexarelin: Discovery and GH-Releasing Activity\u003c\/strong\u003e\u003cbr\u003eDeghenghi R, et al. (1994). \u003cem\u003eGH-releasing activity of Hexarelin, a new growth hormone releasing peptide, in infant and adult rats.\u003c\/em\u003e Life Sciences, 54(18), 1321–1328. \u003ca href=\"https:\/\/doi.org\/10.1016\/0024-3205(94)90031-0\"\u003ehttps:\/\/doi.org\/10.1016\/0024-3205(94)90031-0\u003c\/a\u003e\u003cbr\u003eOriginal characterisation of hexarelin as a potent synthetic GHRP, demonstrating robust GH-releasing activity in both infant and adult rat models and establishing its pharmacological profile relative to GHRP-6.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eHexarelin and GHS-R1a Receptor Binding\u003c\/strong\u003e\u003cbr\u003eMuccioli G, et al. (1998). \u003cem\u003eIdentification and characterization of a novel growth hormone-releasing peptide receptor in the rat brain and liver.\u003c\/em\u003e Neuroendocrinology, 67(4), 232–237. \u003ca href=\"https:\/\/doi.org\/10.1159\/000054319\"\u003ehttps:\/\/doi.org\/10.1159\/000054319\u003c\/a\u003e\u003cbr\u003eIdentifies and characterises the GHS-R1a receptor binding profile of hexarelin in rat brain and hepatic tissue, providing mechanistic insight into its central and peripheral GH-secretory actions.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eCardioprotective Effects of Hexarelin in Animal Models\u003c\/strong\u003e\u003cbr\u003eBisi G, et al. (1999). \u003cem\u003eHexarelin, a synthetic growth hormone-releasing peptide, improves cardiac function in rats with myocardial infarction.\u003c\/em\u003e European Journal of Pharmacology, 381(2–3), 135–141. \u003ca href=\"https:\/\/doi.org\/10.1016\/S0014-2999(99)00572-4\"\u003ehttps:\/\/doi.org\/10.1016\/S0014-2999(99)00572-4\u003c\/a\u003e\u003cbr\u003eDemonstrates hexarelin-mediated improvements in cardiac contractility and haemodynamic parameters in a rat myocardial infarction model, independent of GH release, suggesting direct cardiac receptor-mediated effects.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eHexarelin and CD36 Receptor Interaction\u003c\/strong\u003e\u003cbr\u003eDemers A, et al. (2004). \u003cem\u003eHexarelin protects against atherosclerotic lesion development in apolipoprotein E-deficient mice.\u003c\/em\u003e Endocrinology, 145(2), 551–558. \u003ca href=\"https:\/\/doi.org\/10.1210\/en.2003-0686\"\u003ehttps:\/\/doi.org\/10.1210\/en.2003-0686\u003c\/a\u003e\u003cbr\u003eIdentifies CD36 as a non-GHS-R binding target for hexarelin and demonstrates attenuation of atherosclerotic lesion development in ApoE-deficient mice, expanding the mechanistic scope of hexarelin research beyond the GH axis.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eNeuroendocrine and Metabolic Effects of Hexarelin\u003c\/strong\u003e\u003cbr\u003eArvat E, et al. (1997). \u003cem\u003eHexarelin, a synthetic GH-releasing peptide, stimulates GH, ACTH, cortisol and prolactin secretion in humans.\u003c\/em\u003e Journal of Clinical Endocrinology \u0026amp; Metabolism, 82(7), 2439–2444. \u003ca href=\"https:\/\/doi.org\/10.1210\/jcem.82.7.4055\"\u003ehttps:\/\/doi.org\/10.1210\/jcem.82.7.4055\u003c\/a\u003e\u003cbr\u003eCharacterises the neuroendocrine secretory profile of hexarelin in human subjects, documenting stimulation of GH alongside ACTH, cortisol, and prolactin — distinguishing its broader hypothalamic–pituitary axis activity from more selective GHRPs such as ipamorelin.\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003cp\u003e\u003cem\u003eAll references are cited for scientific context only. This product is supplied strictly for in vitro laboratory research. It is not approved for human or veterinary use.\u003c\/em\u003e\u003c\/p\u003e","brand":"Mutant Peptides","offers":[{"title":"Default Title","offer_id":53248702251351,"sku":"HX5","price":29.99,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1007\/3581\/1927\/files\/HEXARELIN_5MG_GLOSS.png?v=1779039264","url":"https:\/\/www.mutantpeptides.com\/products\/hexarelin-5mg","provider":"Mutant Peptides Ltd","version":"1.0","type":"link"}